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Jeffrey C. Rathmell,* Sarah E. Townsend,* and IL-4, despite the fact that the B cells have become
tolerant to antigen by desensitizing and down-regulatingJiachao C. Xu,† Richard A. Flavell,†
their BCRs (Cooke et al., 1994; Eris et al., 1994). Polar-and Christopher C. Goodnow*
ized delivery (Kupfer et al., 1994) of CD40L and IL-4*Howard Hughes Medical Institute
proteins towards B cells that have captured antigensDepartment of Microbiology and Immunology
via their BCRs and present foreign peptide/MHC com-Stanford University
plexes to T cells may reduce activation of bystander BStanford, California 94305
cells. Tolerant B cells, however, can capture and present†Section of Immunobiology
foreign antigens that either cross-react or form com-Howard Hughes Medical Institute
plexes with self-antigens (Goodnow et al., 1990). ForYale University School of Medicine
example, anti-DNA B cells can use their BCRsto captureNew Haven, Connecticut 06510
viral DNA-binding proteins and present these to virus-
specific T cells. The problem of avoiding delivery of T
cell help to self-reactive B cells is exacerbated by theSummary
tropism of the latter for the T cell rich zones of spleen
and lymph nodes, where foreign antigens are broughtSignals from CD41 T cells induce two opposite fates
by dendritic cells and antibody responses are initiatedin B cells: clonal proliferation of B cells that bind spe-
(Cyster et al., 1994; Cyster and Goodnow, 1995; Fulchercifically to foreign antigens and clonal deletion of
et al., 1996).equivalent B cells that bind self-antigens. This B cell
Fas (CD95/Apo-1) and Fas-ligand (FasL), anotherfate decision is determined by the concerted action
member of the TNF family, may play roles in limitingof two surface proteins on activated T cells, CD40-
mitogenic signals from T cells to tolerant B cells. FasLand Fas-ligands (CD40L and FasL), whose effects are
is displayed on T cells following T cell receptor (TCR)switched by signals from the B cell antigen receptor
signaling (Alderson et al., 1995; Brunner et al., 1995;(BCR). Foreign antigens that stimulate the BCRacutely
Dhein et al., 1995; Ju et al., 1995; Vignaux et al., 1995),cause CD40L and FasL to promote clonal proliferation.
and FasL binding to Fas induces rapid apoptosis in aCD40L and FasL trigger deletion, however, when the
variety of cell types including activated B cells (KrammerBCRs become desensitized by chronic stimulation
et al., 1994; Nagata and Golstein, 1995). When tolerantwith self-antigens or when BCRs have not bound an
B cells present antigen to CD41 T cells in vivo, ratherantigen. The need for both Fas and CD40L to correctly
than proliferate, they are eliminated. This elimination is
regulate self-reactive B cell fate may explain the se-
mediated by FasL/Fas, as it is disrupted if the T cell
vere autoantibody disorders in Fas- or CD40L-defi-
carries a defective FasL gene (FasLgld) or if the tolerantcient children.
B cell carries a mutant Fas gene (Faslpr; Rathmell et
al., 1995). The significance of FasL/Fas interactions for
Introduction preventing autoantibody production is underscored by
the secretion of autoantibodies, resembling those pro-
To avoid autoimmunity, T cells must deliver mitogenic duced in systemic lupus erythematosus (SLE), in mice
signals only to appropriate B cell targets. In cognate carrying the FasLgld or Faslpr mutations (Cohen and Eise-
B–T cell interactions, the immune system must therefore nberg, 1991) and in children with mutations in the Fas
discriminate between useful B cells that have been stim- gene (Fisher et al., 1995; Rieux-Laucat et al., 1995). Fur-
ulated by a foreign antigen binding to their B cell antigen thermore, autoantibody-producing B cells accumulate
receptors (BCRs) and neighboring B cells that either are in large numbers within the T cell zones of the spleen
useless because their BCRs have not been stimulated in Faslpr/lpr mice, consistent with the notion that B–T cell
by an antigen (bystander cells) or are potentially harmful interactions in this site are dysregulated in the absence
because their BCR binds to self-antigens. While the mo- of Fas (Jacobsen et al., 1995).
lecular mechanism by which T cells induce B cell clonal Here we analyze the role of CD40L/CD40, FasL/Fas,
proliferation is becoming clear, much less is known and the BCR in regulating delivery of T cell signals to
about how these cell interactions are regulated to direct eliminate self-tolerant B cells and cause proliferation of
T cell help selectively to foreign antigen-binding B cell foreign antigen-stimulated B cells. To observe how the
targets and minimize secretion of useless or harmful immune system distinguishes between these two
antibody by bystander or tolerant B cells. closely matched B cell targets, the enormous heteroge-
A mechanism to distinguish appropriate B cell targets neity of B and T cell receptors must be circumvented
must exist because T cell–derived mitogens like CD40 by obtaining B and T cells from transgenic mice express-
ligand (CD40L), a member of the tumor necrosis factor ing a uniform BCR or TCR antigen specificity. In this
(TNF) family, and cytokines such as interleukin-4 (IL-4) study the immune response to the well-characterized
have the capacity to trigger proliferation in any B cell, protein antigen, hen egg lysozyme (HEL), is analyzed
regardless of specificity (Armitage et al., 1992; Bancher- either as an injected foreign antigen or as a transgene-
eau et al., 1994; Foy et al., 1996). Thus, self-antigen encoded self-antigen circulating in the blood. B cells
binding B cells that migrate from the bone marrow to with a uniform BCR-specificity for HEL are isolated from
immunoglobulin (Ig) transgenic mice either as naive,the spleen and lymph nodes can proliferate to CD40L
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Figure 1. T Cells Require CD40L to Activate
Tolerant B Cells That Lack Fas and to Elimi-
nate Tolerant B Cells That Have Normal Fas
Genes
(a) Schematic of adoptive transfer approach
used to visualize B–T cell interactions in vivo.
Uniform populations of HEL-tolerant B cells
were obtained from Ig-transgenic mice that
expressed HEL as a circulating self-antigen.
Uniform populations of HEL-reactive T cells
were obtained in parallel from TCR-trans-
genic mice. B and T cells were mixed and
injected into the circulation of histocompati-
ble mice, where the cells could home to the
spleen and interact.
(b and c) Fate of tolerant B cells with a Fas
defect. Tolerant B cells from Fas lpr/lpr mice
were transferred with T cells that were not
HEL-reactive from wild type (wt) nontrans-
genic mice or with TCR-transgenic T cells that either carried a wild-type CD40L gene or were CD40L-deficient (CD40L2/Y). Three days after
transfer, activation of the B cells was analyzed in the spleen by flow cytometry to measure B cell enlargement by forward light scatter (b) and
recovery of cell surface IgM antigen receptor levels (c). Histograms shown are gated on the transferred B cells by staining for their HEL-
binding BCRs.
(d) Fate of tolerant B cells with wild-type Fas genes. Tolerant B cells that were Fas1/1 (closed circles) or Faslpr/lpr (open circles) were transferred
with T cells of the indicated genotypes as in (b and c). Five days after transfer, the B cells were enumerated in the spleen by flow cytometry.
Each dot represents the number of HEL-binding B cells in the spleen of individual recipient mice. Separate T cell donors were used for each
recipient in (d), to control for any background genetic heterogeneity among the CD40L-deficient mice and their littermates. Equivalent results
were obtained in three later experiments where cells from separate T cell donors were pooled into CD40L1/Y and CD40L2/Y populations.
nontolerant B cells that have never encountered HEL 1995). CD40L was a likely candidate for the mitogenic
signal from T to B cells that was revealed in the absenceantigen, or as tolerant B cells that have matured in mice
where they were continuously exposed to HEL as a self- of Fas-induced deletion, because tolerant B cells ex-
press CD40 normally and can proliferate to isolatedantigen and have desensitized and down-regulated their
BCRs (Goodnow et al., 1988; Cooke et al., 1994). HEL- CD40 signals in vitro (Cooke et al., 1994; Eris et al.,
1994). To examine the role of CD40L, CD41 T cells fromspecific CD41 T cells are obtained in parallel from
transgenic mice carrying rearranged TCR a and a chain TCR-transgenic mice that were wild type (CD40L1/1),
heterozygous (CD40L1/2), or hemizygous (CD40L2/Y) forgenes specific for the dominant HEL 46–61 peptide
bound to the major histocompatibility complex (MHC) a targeted mutation in the X-linked CD40L gene (Xu et
al., 1994) were used in adoptive transfer experimentsmolecule I-AK (Ho et al., 1994). We show that both CD40L
and FasL have dual and essential roles directing B cell with tolerant B cells from Faslpr/lpr mice (Figure 1a). Three
days after transfer with CD40L1/1 T cells, flow cytometricclonal expansion or elimination following interaction
with helper CD41 T cells. The effect of these molecules analysis revealed that the tolerant B cells had been in-
duced to enlarge (Figure 1b) and recover their surfaceis switched from causing elimination to proliferation by
the timing of BCR stimulation by antigen. This mecha- IgM expression (Figure 1c), consistent with the activa-
tion and blastogenesis observed previously (Rathmellnism thus promotes clonal expansion and antibody pro-
duction by useful B cells that have bound foreign antigen et al., 1995). In contrast, when CD40L-deficient T cells
were transferred, B cell size and surface IgM expressionacutely and minimizes secretion of harmful autoanti-
bodies by B cells that have bound self-antigens repeat- remained identical to controls that were transferred with
nontransgenic CD41 T cells that do not recognize theedly. Disruption of this pathway may explain the auto-
antibody-mediated disease that often accompanies HEL antigen, indicating a requirement for CD40L to reac-
tivate Faslpr/lpr tolerant B cells.X-linked CD40L-deficiency as well as inherited Fas-defi-
ciency.
FasL and CD40L Are Both Necessary
for Elimination of Tolerant B CellsResults
by CD41 T Cells
The failure of tolerant B cells from Faslpr/lpr mice to beT Cell-Derived CD40L Is Required
to Stimulate Tolerant B Cells stimulated by CD40L-deficient T cells implied that
CD40L was induced on wild-type T cellsby TCR recogni-In previous in vivo B–T cell interaction experiments
(schematized in Figure 1A), we found that HEL-tolerant tion of the HEL 46–61/I-AK complexes on tolerant B cells
(Ho et al., 1994; Kanost and McCluskey, 1994). To testB cells in the spleen and lymph nodes were selectively
eliminated by HEL-specific T cells when their migration whether CD40L had any effect when the FasL/Fas path-
way was intact, CD40L-deficient (CD40L2/Y) T cells werewas tracked ina thirdparty mouse (Rathmell etal., 1995).
The B cells escapeddeletion, however, and instead were compared with CD40L1/2 or CD40L1/1 controls upon
adoptive transfer with tolerant B cells that carried wild-triggered into proliferation if the B cells carried a homo-
zygous Fas mutation (Faslpr/lpr) or if the T cells were het- type Fas genes (Figure 1d). Five days after transfer, HEL-
binding B cells were enumerated in each recipient flowerozygous for a FasL mutation (FasLgld/1; Rathmell et al.,
Effects of CD40L and FasL on B Cell Fate
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Figure 2. T Cells Require CD40L to Induce Fas on Tolerant B Cells
(a–e) Tolerant B cells from Faslpr/lpr (a and e) or Fas1/1 mice (b–e) were transferred with T cells and analyzed by flow cytometry 5 days later as
in Figure 1. HEL-specific T cells from TCR-transgenic mice were either FasL-deficient (FasLgld/1), CD40L-deficient (CD40L2/Y), or wild type
(CD40L1/1). Histograms in (a–d) show intensity of staining for Fas expression on HEL-binding B cells with the mean Fas fluorescence intensity
shown in the upper right corner of each panel. (e) Pooled data from four experiments as in (a–d). Each dot represents Fas staining on B cells
in an individual recipient.
(f) FasL-deficient T cells, which are able to induce Fas on tolerant B cells, can trans-complement the deficit in CD40L-deficient T cells. Tolerant
B cells carrying wild-type Fas genes were transferred as in Figure 1 with either 7 3 105 CD41 T cells of the indicated individual genotypes or
with a mixture of T cells comprising 3.5 3 105 FasLgld/1 and 3.5 3 105 CD40L2/Y CD41 cells. Each dot represents the number of HEL-binding
B cells in the spleen of individual recipient mice five days after transfer.
(g and h) Schematic explaining the requirement for CD40L and trans-complementation by FasL-deficient T cells. When tolerant B cells present
HEL peptide to CD40L-deficient T cells (g), Fas is not induced on the B cell and deletion, therefore, cannot be triggered by FasL. Presentation
to FasL-deficient T cells induces CD40L and causes Fas to be upregulated on the B cell (h), but the T cell is unable to eliminate the B cell
because of FasL-deficiency. Subsequent interaction between the B cell, which has now been activated, and a CD40L-deficient T cell, restores
elimination of the tolerant B cell because CD40L-deficient cells retain the capacity to make FasL.
cytometrically. Control CD40L1/1 or CD40L1/2 T cells indicates that tolerant B cells are indeed able to interact
with multiple T cell partners. CD40L on FasL-deficienteliminated Fas1/1 B cells (closed dots) but were unable
to eliminate Faslpr/lpr B cells (open dots). Surprisingly, T cells first causes B cells to upregulate Fas, and FasL
on CD40L-deficient T cells then eliminates the B cell.CD40L-null T cells (CD40L2/Y) failed to eliminate both
Fas1/1 and Faslpr/lpr B cells. In this case the tolerant B The cumulative effect of multiple T cell partners on B
cell fate may be significant for heterozygous female car-cells also failed to be activated by CD40L2/Y T cells (data
not shown). riers of defective CD40L genes, in whom random
X-inactivation would create a subset of CD40L-deficientThe requirement for CD40L in the T cell to trigger Fas-
dependent elimination of tolerant B cells could reflect T cells (Hollenbaugh et al., 1994).
a requirement for CD40L to stimulate Fas expression,
as tolerant B cells express very little Fas when isolated CD40L and Fas Both Contribute to Clonal
Expansion of Foreign-Antigen Reactivefrom donor mice or transferred without HEL-specific T
cells (Figure 2b, 2e, and data not shown). To test this B Cells by CD41 T Cells
The results above indicate that CD41 T cells displaynotion, tolerant B cells were transferred with FasLgld/1 T
cells that are unable to eliminate the B cell targets owing CD40L and FasL when interacting with tolerant B cells
and both molecules are required to eliminate self-anti-to FasL-deficiency. In the presence of FasL-deficient
CD41 cells, specific staining for Fas increased 5-fold on gen presentingB cells. NontolerantB cells with the same
BCR specificity as the tolerant B cells, but originatingthe tolerant B cells within 3 days (Figures 2c and 2e).
By contrast, no significant increase in Fas expression from a BCR-transgenic mouse that does not express
HEL as a self-antigen, bind and present HEL when itoccurred on tolerant B cells upon interaction with HEL-
specific T cells that were CD40L-deficient (Figures 2d is encountered acutely as a foreign antigen. They are,
however, not eliminated upon interaction with the sameand 2e). CD40L-deficient T cells were functional in other
respects, as they could correct the functional defect in CD41 T cells that eliminated the tolerantB cells (Rathmell
et al., 1995). We tested whether this could be due toFasL-deficient T cells in a trans-complementation assay
(Figure 2f; shown schematically in Figures 2g and 2h). Fas remaining uninduced. For this purpose, nontolerant
B cells were taken from a BCR-transgenic mouse andIn this experiment tolerant B cells could present antigen
to T cell partners with molecular deficits in either CD40L adoptively transferred with HEL-specific T cells into
mice that were immunized with foreign HEL antigen.or FasL. The ability of the two defective T cell types
to trans-complement one another for B cell elimination Staining for Fas on the B cells showed that Fas was in
Cell
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Figure 4. T Cells Do Not EliminateFas-Expressing B Cells That HaveFigure 3. T Cells Induce Fas on Nontolerant B Cells That Have Been
Been Acutely Stimulated by AntigenAcutely Stimulated by Foreign HEL Antigen
(a–d) Nontolerant B cells from Fas1/1 mice (closed circles), markedNontolerant B cells from Faslpr/lpr (thin histograms) or Fas1/1 (thick
by the Ly5a allele of CD45, were mixed with nontolerant B cells fromhistograms) Ig-transgenic mice were adoptively transferred as in
Faslpr/lpr (open circles) mice and transferred with T cells as in FigureFigure 1 with T cells carrying wild type CD40L genes (a and b;
1. The recipient mice either lacked HEL antigen (a and b) or wereCD40L1/1), with CD40L-deficient T cells (c; CD40L2/Y), or in the ab-
HEL transgenic (c and d) so that HEL was encountered acutely bysence of T cells (d). In (b)–(d), recipients were immunized with 0.5
the B cells as a new serum protein. The relative clonal expansionmg HEL antigen in PBS intraperitoneally at the time of cell transfer.
and differentiation of Fas-bearing and Fas-deficient B cells wasFas expression on HEL-binding B cells in the spleen was analyzed
compared five days after transfer by enumerating the frequency ofby flow cytometry three days after transfer. Mean fluorescence in-
transferred Ly5a1 and Ly5a2 B cells (bearing IgMa; a and c) andtensity is shown for each panel.
comparing the frequency of B cells that had acquired the plasma
cell marker, Syndecan (b and d).
fact increased 10-fold (Figures 3a and 3b). In parallel, (e) Relative clonal expansion. The number of HEL-binding Ly5a1
Fas was induced 3- to 4-fold on nontolerant B cells (Fas1/1) and Ly5a2 (Faslpr/lpr) B cells in the spleen of individual recipient
mice is shown.transferred with antigen plus CD40L-deficient T cells,
compared with negligible Fas induction on B cells ex-
posed to antigen but without antigen specific T cells
formed Syndecan1 plasma cells less well than Fas1/1 B(Figures 3c and 3d). Thus, in contrast to the complete
cells (Ly5a1; Figures 4c–4e). These data indicate that Fasrequirement of CD40L to upregulate Fas on tolerant B
does not trigger appreciable apoptosis of proliferatingcells (Figure 2), Fas is induced on nontolerant B cells
B cells responding to foreign HEL antigen and CD41 Tduring cognate interactions and CD40L contributes only
cells. Moreover, transfers with CD40L-deficient T cellspartially to Fas induction in this context.
indicated that expression of Fas promoted mitogenesisExpression of Fas on nontolerant B cells during cog-
in this context. Thus when Fas1/1 nontolerant B cellsnate interactions with T cells could have triggered
were transferred with CD40L-deficient T cells, their pro-apoptosis of some B cells that was masked by compen-
liferation and antibody secretion was 30-fold lower thansatory B cell clonal proliferation. In this case, Fas-
when transferred with CD40L1/Y T cells (Figures 5a andexpressing B cells would be expected to have a prolifer-
5b). The antibody response was nevertheless 10,000-ative disadvantage relative to Fas-deficient B cells,
fold above the background counts generated in the ab-since the latter could not be eliminated by this process.
sence of antigen-specific T cell help, consistent withTo test this possibility, the proliferative and antibody
the notion that other mitogenic signals in addition toproducing capacities of Fas1/1 and Faslpr/lpr nontolerant
CD40L function during B–T cell interaction (Parker, 1993;B cells were compared side-by-side in an adoptive co-
Clark and Ledbetter, 1994). Clonal expansion and anti-transfer, employing allelic differences at the Ly5 locus
body formation by Faslpr/lpr B cells was reduced moreto distinguish them flow cytometrically. In shared recipi-
ents, Fas-deficient B cells (Ly5a2) clonally expanded and drastically, by 300- to 1000-fold, when CD40L-null T
Effects of CD40L and FasL on B Cell Fate
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nontolerant B cells that have acquired antigen indepen-
dent of their BCR specificity (bystander B cells).
A mutantHEL protein, Tri-Ala HEL, with alaninesubsti-
tutions at three key residues involved in the binding of
the 46–61 peptide to the I-AK molecule (Allen et al., 1987),
was used to further dissect the role of acute BCR stimu-
lation (see Figure 6a, schematic). The alanine substitu-
tions in Tri-Ala HEL abolish binding to I-AK and prevent
presentation to the TCR-transgenic T cells but preserve
normal binding and stimulation of HEL-specific BCRs
on the B cells (S. E. T. and C. C. G., unpublished data). By
selectively restoring BCR stimulation with Tri-Ala HEL inFigure 5. Fas Promotes Clonal Expansion and Antibody Secretion
this way, peptide-loaded B cells were protected fromin B Cells That Have Been Acutely Stimulated by Antigen and CD40L-
Fas-dependent elimination by the T cells (Figure 6c).Deficient T Cells
The combination of Tri-Ala HEL and HEL 46–61 peptideNontolerant B cells from Fas1/1 (closed circles) or Faslpr/lpr (open
circles) mice were transferred with T cells of the indicated genotypes did not cause proliferation and increase B cell numbers
as in Figure 1 into mice expressing HEL as a soluble serum protein. B to the extent that occurred with intact HEL protein (Fig-
cell clonal expansion (a) and differentiation into antibody-secreting ure 6b), possibly because a pool of internalized HEL
cells (b) were measured in the spleen five days after transfer by flow
was not present to replenish peptide/I-AK complexes oncytometry to enumerate HEL-binding B cells (a) or by spot ELISA to
dividing cells. Nevertheless, B cells treated with Tri-Alacount antibody-forming cells (b). Each circle represents the numbers
HEL and peptide formed large blast cells in responsefrom spleens of individual recipient mice. Equivalent results were
obtained in two separate experiments. to the combination of BCR-mediated signal and cognate
T cell help (Figure 6d).
cells were used as helpers. Fas expression by nontoler- Discussion
ant B cells, therefore, promoted clonal expansion during
interactions with T cells. The findings described here illustrate a novel mecha-
nism by which inductive immune cells restrict mitogenic
Nontolerant B Cells Are Eliminated through Fas signals to appropriate target cells in vivo by modulating
When They Present Antigen to T Cells in the the effect of two TNF-related molecules from mitosis to
Absence of BCR Receptor Stimulation apoptosis. Specifically, these data are significant for
The data above indicates that CD40L and Fas acted understanding how cognate B–T cell interactions are
together to induce opposite fates in B cells that differed regulated in vivo to direct T cell help to protective B
only by their prior antigenic experience: both were cells that make antibodies specifically against foreign
needed for elimination of tolerant B cells that had bound antigens while minimizing secretion of irrelevant or self-
self-antigens chronically and both promoted prolifera- reactive antibodies. By tracking the outcome of interac-
tion of nontolerant B cells that had been acutely stimu- tions between controlled populations of B and T cells
lated by foreign antigen. Because tolerant B cells are in vivo, CD40L and FasL/Fas together were shown to
distinguished from nontolerant B cells only by dimin- trigger opposite cell fates depending on stimulation of
ished BCR numbers and signaling (Cooke et al., 1994), the B cells’ antigen receptors. T cell–derived CD40L was
it was possible that signals from the BCR determined required to activate and induce Fas on B cells that had
which fate was induced. This possibility predicts that not bound antigen via their BCR (irrelevant or bystander
nontolerant B cells would also be eliminated if they cap- B cells) and on tolerant B cells that had already bound
tured and presented antigen to T cells in a way that self-antigen repeatedly so that signaling by their BCRs
bypassed BCR engagement and signaling. To test this was desensitized. FasL then brought about deletion of
hypothesis, BCR stimulation by foreign HEL antigen was the irrelevant or self-reactive B cell. By contrast, CD40L
bypassed by directly loading nontolerant B cells with and FasL/Fas both promoted clonal expansion and anti-
HEL 46–61 peptide in vitro prior to in vivo transfer with body production in B cells that had been stimulated
T cells (schematic in Figure 6a). The stability of the MHC/ acutely by foreign antigen binding to their BCRs. The
peptide complex is high, as I-AK molecules presenting failure of this mechanism for blocking inductive signals
the HEL 46–61 peptide have a half-life of >22 hr (Nelson to tolerant B cells provides a potential explanation for
et al., 1994). Three days after transfer with Tcells, control the severe autoantibody disorders that occur in CD40L-
B cells that had been incubated in media alone remained deficient or Fas-deficient children.
resting since they carried no peptide ligand for the TCR,
and B cells exposed to intact HEL protein enlarged and Model for CD40L/Fas-Dependent
proliferated extensively (Figures 6b–6d). By contrast, Regulation of B–T Interactions
HEL 46–61 peptide-loaded B cells were eliminated in The data above suggest the following model (Figure 7)
the presence of HEL-specific CD41 cells (Figures 6b and to explain how the antigenic history of the B cell, CD40L,
6c). This elimination was Fas-dependent, as peptide- and FasL/Fas regulate B cell fateduring cognate interac-
loaded Faslpr/lpr B cells were not eliminated upon transfer tions with CD41 T cells. Tolerant B cells that capture
with HEL-specific T cells (Figure 6c). Susceptibility to antigen through desensitized antigen receptors, or by-
Fas-dependent eliminationby CD41 T cells in vivo, there- stander B cells that capture antigen through BCR-inde-
pendent routes (Figure 7a), fail to receive a completefore, is not unique to tolerant B cells but also occurs in
Cell
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Figure 6. Acute BCR Stimulation Protects Nontolerant B Cells from Fas-Mediated Elimination by T Cells
(a) Schematic illustrating the approach used to bypass BCR stimulation by direct MHC-loading with HEL peptide, and the approach to restore
BCR stimulation selectively with Tri-Ala HEL that cannot be presented to the T cell.
(b) Nontolerant B2201 B cells from Fas1/1 Ig-transgenic mice were exposed in vitro for 4 hr to media alone, media containing 500 ng/ml HEL,
or media containing 10 mM HEL 46–61 peptide. The loaded B cells were then washed and transferred with T cells into recipients that lacked
any HEL. Three days after transfer, clonal expansion or elimination was measured by enumerating HEL-binding B cells in the spleen flow
cytometrically as in Figures 1–5.
(c and d) Comparison of the fate of nontolerant B2201 B cells from Fas1/1 (closed circles) or Faslpr/lpr (open circles) mice after in vitro exposure
to the indicated stimuli and transfer with T cells as in (b). The number of HEL-binding B cells in the spleen of individual recipients three days
after transfer is shown in (c) and the size of the Fas1/1 B cells is shown in (d). Numbers in the upper right indicate the mean forward light
scatter and standard deviation for the B cells in the three recipient mice in each experimental group.
set of intracellular signals from their BCR. Consequently promotes mitogenesis (Figures 7e and 7f). In this model,
CD40L and Fas comprise a checkpoint late in cognatethey are not induced to express CD86 (B7.2), the ligand
for CD28, and present antigen to specific T cells in the B–T interactions in the T cell zones of spleen and lymph
node that aborts mitosis in B cell clones by causing theirabsence of costimulation (Cooke, et al., 1994; Eris et
al., 1994; Ho et al., 1994; Cyster and Goodnow, 1995). elimination unless they have been acutely stimulated by
a newly appearing antigen, as would occur for cells thatUnder these conditions, T cells respond by displaying
CD40L and FasL (inferred from genetic results here) but bind specifically to foreign determinants on infectious
antigens.make little IL-2 or IL-4 cytokines (Ho et al., 1994). CD40L
engagement of CD40 on B cells has both a weak mito-
genic effect and causes Fas up-regulation (Figure 7b). Modulation of CD40L/FasL Effects by the B
Cell Antigen ReceptorLigation of Fas by FasL on the T cell then results in
apoptotic elimination of tolerant or bystander B cells The paradoxical finding that a mitogenic signal, CD40L,
is also required in vivo to up-regulate Fas on B cells(Figure 7c).
By contrast, nontolerant B cells that are acutely stimu- and render them susceptible to Fas-mediated apoptosis
(Figures 1d and 2) is consistent with in vitro data demon-lated by a new foreign antigen receive the full spectrum
of intracellular signals from their BCR (Figure 7d), lead- strating CD40-induced Fas expression and sensitization
to apoptosis (Garrone et al., 1995; Rothstein et al., 1995;ing to B cell activation and expression of CD86 (Cooke
et al., 1994; Ho et al., 1994; Lenschow et al., 1994; Cyster Schattner et al., 1995; Lens et al., 1996; Wang et al.,
1996). This negative regulatory role of CD40L/CD40and Goodnow, 1995). The combined TCR and CD28
signals received by the T cell result in cytokine secretion stands in contrast to its ability to promote germinal cen-
ter B cell survival and protect against antigen receptor–(Linsley and Ledbetter, 1993; Ho et al., 1994) in addition
to CD40L and FasL expression. Because of prior BCR mediated apoptosis in primary B cells and B lymphomas
in vitro (Liu et al., 1989; Valentine and Licciardi, 1992;signaling and/or IL-4 stimulation, binding of FasL to Fas
on the B cell does not eliminate the B cell but instead Tsubata et al., 1993; Santos-Argumedo et al., 1994; Choi,
Effects of CD40L and FasL on B Cell Fate
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Figure 7. Model for Sequential Steps
Allowing Elimination of Self-Tolerant or By-
stander B Cells and Proliferation of Foreign
Antigen-Specific B Cells during Cognate B–T
Cell Interactions
See text for details.
1995; Merino et al., 1995; Wang et al., 1995). CD40L/ mechanism by which Fas is prevented from transmitting
an apoptotic signal in acutely antigen-activated B cellsCD40 do not appear to act directly to eliminate tolerant
B cells, as has been described for some lymphomas may involve modulation of Fas isoforms, of Fas-associ-
ating proteins, or of downstream death-regulatory mole-(Inui et al., 1990; Funakoshi et al., 1994), because CD40L
stimulates Fas-deficient tolerant B cells (Figures 1b and cules (Oltvai and Korsmeyer, 1994; Fraser and Evan,
1996). The enhanced proliferation of B cells expressing1c), and despite functional CD40L, tolerant B cells are
not eliminated in the absence of Fas/FasL interaction Fas compared with Fas-deficient B cells (Figure 5) may
have been caused directly by Fas stimulating B cell(Figures 1d and 2d). Consistent with the importance of
acute BCR stimulation demonstrated here, in vitro mitosis or indirectly by Fas/FasL interaction causing
mitogenic cytokines to be produced by either B or Tmodel systems have shown that B cells that are sensi-
tized to Fas-mediated apoptosis by CD40 can be pro- cells (Alderson et al., 1993; Abreu-Martin et al., 1995).
It is important to note that BCR crosslinking and sig-tected by signals from the BCR (Rothstein et al., 1995;
Lagresle et al., 1996; Wang et al., 1996). The results here naling is not an all-or-none event, and that acute
changes in the extent of BCR cross-linking also influ-confirm in vitro data and illustrate how these signals
function within primary B and T lymphocytes in vivo to ence the outcome of interactions between tolerant B
cells and T cells (Cooke et al., 1994). Tolerant B cellsguide T cell help to useful B cells and block help to
potentially harmful B cells in cognate interactions in the can be stimulated to proliferate (albeit at reduced levels)
by T cells following a shift from chronic binding of solu-spleen and lymph node. The data also demonstrate that
instead of being merely sufficient, CD40L is required for ble HEL self-antigen to acute stimulation by foreign HEL
as a multimeric antigen array on cell membranes. AnFas-mediated elimination of tolerant B cells (Figure 1d).
Signals from a sudden burst of BCR cross-linking by acute increase in BCR cross-linking by membrane HEL
or by polyclonal anti-BCR antibodies partially over-antigen are likely to protect against Fas-mediated death
both by direct effects within the B cell and by inducing comes BCR desensitization in HEL-tolerant B cells at
the level of receptor phosphorylation, calcium flux, andT cells to display B cell survival factors. In vitro model
systems have clearly illustrated the former, as BCR en- CD86 induction (Cooke et al., 1994). Similarly, B cell
tolerance to theglycoprotein of vesicular stomatitis virusgagement in this case protected B cells from Fas-medi-
ated apoptosis during brief lectin-induced interactions (VSV) expressed at low levels as a self-antigen in
transgenic mice could be overcome selectively whenwith FasL-expressing T cell clones or during treatment
with anti-Fas antibody (Rothstein et al., 1995; Lagresle challenged with VSV glycoprotein in a dense multivalent
matrix on virus particles (Bachmann et al., 1993). Theet al., 1996; Wang et al., 1996). Protective effects acting
through the T cell are also likely because acute BCR capacity to recruit low avidity self-tolerant B cells into
primary antibody responses, despite a markedly raisedcross-linking induces CD86 and strongly costimulates
excitation threshold and reduced expansion potential,cytokine secretion by interacting T cells. Indeed, while
may balance self-tolerance against the need to drawtolerant or bystander B cells express little CD86 at the
upon the maximum diversity of clones early in infectiontime of antigen presentation and induce little cytokine
(Goodnow, 1996).secretion by HEL-specific T cells, nontolerant B cells
acutely activated by HEL initially express CD86 at high
levels and trigger production of mitogenic cytokines Implications of CD40L/Fas-Dependent Regulation
for Immunity and Autoimmunity(Cooke et al., 1994; Ho et al., 1994; Lenschow et al.,
1994). Cytokines such as IL-2 and IL-4 are potent growth The transgenic model system employed here is particu-
larly amenable to the study of in vivo B–T lymphocyteand survival factors for B cells and may also block Fas-
mediated apoptosis (Parker, 1993; Clark and Ledbetter, interactions because primary T and B cells are available
that are specific for the same antigen and the B cells1994; Wang et al., 1996). Expression of CD40L on T cells
is also augmented by CD28-mediated costimulation differ only in their history of antigenic exposure. This
allows the mechanism and the outcome of B–T cell inter-(Klaus et al., 1994), and these quantitative differences
in the level of CD40L could conceivably affect the induc- actions to be compared with closely matched nontoler-
ant or tolerant B cells in vivo. HEL-induced IgM antibodytion of cell death by FasL. In either case, the intracellular
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(nontolerant B cells) or together with the ML5 soluble HEL transgeneproduction by the nontolerant B cells is entirely T cell
(HEL-tolerant B cells). MD4 encodes an anti-HEL immunoglobulindependent in this system (Figure 5), as it is in non-
with both IgM and IgD isotypes and ML5 encodes HEL expressedtransgenic mice, and the mechanisms of tolerance that
as a serum protein (Goodnow et al., 1988; available from Induced
have been described to regulate tolerance to HEL are Mutant Repository of the Jackson Laboratories). Transgenic Faslpr/lpr
the same as those described for bona fide SLE-autoanti- mice were bred as described (Rathmell and Goodnow, 1994). The
gens, such as DNA and erythrocytes (Erikson et al., 1991; I-AK restriction element for HEL presentation to the 3A9 TCR-
transgenic T cells was introduced by breeding to B10.BR/SgSnJOkamoto et al., 1992). The use of irradiated recipients
and backcrossing to C57BL/6J-Faslpr/lpr three generations, selectinghere to reduce the number of bystander lymphocytes
for Faslpr/lpr homozygosity and H-2k/b heterozygosity at each genera-and to facilitate tracking the fate of HEL-specific B–T cell
tion by PCR, as described (Rathmell et al., 1995). C57BL/6J-Ly5ainteractions in vivo is a potentially significant difference
congenic MD4 transgenic mice were crossed to B10.BR/SgSnJ to
from the normal situation. We nevertheless find that the yield the (C57BL/6J-Ly5a 3 B10.BR/SgSnJ)F1 Fas1/1 animals used
same results occur when the cells are transferred into in cotransfer.
unirradiated normal mice, where the rare antigen-spe- T cells for adoptive transfer were from (C57BL/6J 3 B10.BR/
SgSnJ)F1 mice that were either nontransgenic or carried the 3A9cific cells are competing with the normal excess of by-
TCR a and b transgenes (Ho et al., 1994). CD40L-deficient micestander B and T cells (S. E. T. and C. C. G., unpublished
were generated as described (Xu et al., 1994) and backcrosseddata). Although one limitation of the model is the inability
several generations to C57BL/6J. Female heterozygotes for theto study the fate of B cells that have switched to IgG,
CD40L deletion were crossed with 3A9 transgenic B10.BR/SgSnJ
Fas and CD40L are clearly implicated in regulating the animals. Mice were screened by PCR for disruption of the CD40L
fate of IgM1 cells in other settings. Thus, Fas-deficient gene. Male 3A9 transgenic mice hemizygous for the X-linked CD40L
mice have hyper-IgM secretion, IgMautoantibodies (Co- mutation were used as CD40L-deficient T cell donors, and wild-
type male littermates or heterozygous females were used as con-hen and Eisenberg, 1991), and dysregulated prolifera-
trols. Mice heterozygous for the FasLgld mutation were used as FasL-tion of IgM-producing cells in the T cell zones (Jacobsen
deficient T cell donors. T cells from these mice do not expresset al., 1995). Similarly, CD40L-deficient children often
sufficient FasL to eliminate Fas1/1 self-tolerant B cells (Rathmell etmanifest with hyper-IgM secretion and autoantibodies
al., 1995) but develop in a normal background and do not suffer
(see below). Because human memory B cells express from potential secondary effects that autoimmunity may cause. 3A9
Fas but are resistant to Fas-mediated apoptosis (Liu et transgenic (C57BL/6J-FasLgld/gld 3 B10.BR/SgSnJ)F1 animals were
al., 1995), it will be important to define how Fas-medi- backcrossed to C57BL/6J-FasLgld/gld, and offspring were screened
by PCR for the 3A9 transgene, H-2k/b heterozygosity, and heterozy-ated killing is modulated during secondary responses.
gosity for the FasLgld mutation. A PCR screening for the FasLgld pointUsing this transgenic model we show that CD40L has
mutation in FasL was developed using the MS–PCR approach (Rusttwo important functions for B cells during B–T interac-
et al., 1993). A forward primer (AGG AAC TCT AAG TAT CCT GAG)tions, namely to promote mitosis and to induce Fas
upstream of the mutation was used to amplify FasL with reverse
expression and hence apoptosis. The finding that primers specific for the FasLgld (AGA TCA TTT TAA AAT GCT TTT
CD40L is required to induce Fas in the pathway that GAT TTT AAA GCT TAT ACA AGC CGA GAA G) and wild-type (TCT
leads CD41 T cells to eliminate self-tolerant B cells (Fig- TTT AAA GCT TAT ACA AGC CGA AGA A) alleles. The differing
lengths of the two reverse primers produce products of 202 bp andures 1d and 2) may help explain the autoantibody disor-
181 bp, respectively, that can be distinguished electrophoretically.ders that often compound the management of human
Recipient animals in each adoptive transfer assay were (B10.BR/CD40L-deficient X-linked hyper-IgM (X-HIM) patients
SgSnJ x C57BL/6J)F1 nontransgenic or ML5 soluble HEL transgenic.(Hinz and Boyer, 1963; Ackerman, 1964; Rosen and
Donor and recipient mice were between 6 and 20 weeks of age.
Janeway, 1966; Aruffo et al., 1993; DiSanto et al., 1993; Sexes were matched as far as possible, although no difference was
Kortha¨uer et al., 1993; Ramesh et al., 1993). These pa- observed between male and female mice in the adoptive transfer
tients often present with autoimmune hemolytic anemia assays described. Mice were MHC matched in all experiments. Few
histocompatibility differences exist between the C57BL/6 andand autoimmune thrombocytopenia, the same spectrum
C57BL/10 strain backgrounds and would thus be unlikely to createof autoantibodies that occur in Fas-deficient individuals
appreciable allogeneic effects in the 3–5 day transfer period. Resid-(Fisher et al., 1995; Rieux-Laucat et al., 1995) and in the
ual minor histocompatibility antigen differences between 129/Svgenetically undefined human disorder, Evans Syndrome
(from the CD40L knockout mice) and the B10/B6 stock may have
(Pui et al., 1980). Clonal expansion and antibody secre- remained in some donor animals after several generations back-
tion by autoreactive B cells in CD40L-deficient patients crossing to C57BL/6J. The effects of these possibleminor histocom-
must be driven by other T cell–derived signals, such as patibility differences were minimized by the small numbers of cells
IL-2, IL-4 (Parker, 1993; Clark and Ledbetter, 1994), or tranferred and the short-term (3–5 day) assay period and were con-
trolled for by using multiple littermate donors of each genotypeOX-40 (Stu¨ber et al., 1995), or by T-independent path-
(CD40L 1/1, 1/2, 1/Y, and 2/Y).ways. CD40L-independent mitogenic signals, however,
may not substitute for CD40L in inducing Fas expression
Donor Cell Preparationand rendering self-tolerant B cellssensitive toFas-medi-
Whole spleen cell suspensions from B cell donors were adoptivelyated cell death, so that proliferating self-tolerant B cells
transferred unless otherwise noted. Spleen cells were isolated byescape censoring by the Fas pathway. It will be interest-
passing through a metal sieve and counted by hemocytometer.
ing to test whether defects in this CD40L-Fas pathway When B2201 enriched cells were transferred, B celldonor spleen cell
contribute to autoimmunity in other examples of Evans suspensions were incubated with magnetic anti-B220 microbeads
syndrome and in other autoantibody-associated dis- (Miltenyi Biotec, Germany), as described by the manufacturer, fol-
orders. lowed by a single pass over a MiniMACS column. Cells from T cell
donors were isolated by passing pooled spleen, mesenteric, and
inguinal lymph node cells through a metal sieve and counted byExperimental Procedures
hemocytometer. CD41 T cells were enriched by incubating pooled
cell suspensions with magnetic anti-CD4 microbeads (Miltenyi Bio-Mice
tec), followed by two passes over MiniMACS columns. Purity of theB cells were from transgenic (C57BL/6J 3 B10.BR/SgSnJ)F1 mice
carrying the MD4 anti-HEL immunoglobulin H 1 L transgenes alone resulting CD41 cell populations ranged between 85% and 98% with
Effects of CD40L and FasL on B Cell Fate
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an average of 93%, and the purity of the resulting B2201 cell popula- E., Schooley, K., Ramsdell, F., and Lynch, D.H. (1993). Fas trans-
duces activation signals in normal human T lymphocytes. J. Exp.tions was between 90% and 95%. B2201 cells enrichment from
Faslpr/lpr spleens resulted in 64% purity of HEL-binding B cells. The Med. 178, 2231–2235.
poor enrichment was caused by CD42CD82Thy11B2201 T cells in Alderson, M.R., Tough, T.W., Davis-Smith, T., Braddy, S., Falk, B.,
Faslpr/lpr spleens. Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, F., and Lynch,
D.H. (1995). Fas ligand mediates activation-induced cell death in
human T lymphocytes. J. Exp. Med. 181, 71–77.Antigen Loading In Vitro
B2201-enriched B cell populations were cultured for 4 hr at 378C, Allen, P.M., Matsueda, G.R., Evans, R.J., Dunbar, J.B., Marshall,
5% CO2 at 2 3 106 cells/ml in 5 ml complete media in 6-well plates G.R., and Unanue, E.R. (1987). Identification of the T-cell and Ia
(COSTAR, Cambridge, MA). HEL (Sigma, St Louis, MO) or Tri-Ala contact residues of a T-cell antigenic epitope. Nature 327, 713–715.
HEL was added to the medium at a final concentration of 500 ng/ Armitage, R.J., Fanslow, W.C., Strockbine, L., Sato, T.A., Clifford,
ml. HEL 46–61 peptide was added to a final concentration of 10 K. N., Macduff, B.M., Anderson, D.M., Geimpel, S.D., Davis-Smith,
mM. Tri-Ala HEL was produced by expression in the yeast Pichia T., Maliszewski, C.R., et al. (1992). Molecular and biological charac-
pastoralis and purified by ion-exchange chromatography. The de- terization of a murine ligand for CD40. Nature 357, 80–82.
sign, production, and detailed characterization of Tri-Ala HEL will
Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A.,be described elsewhere (S. E. T., unpublished data). After culture
Nonoyama, S., Bajorath, R., Grosmaire, L.S., Stenkamp, R., Neu-the cells were washed, counted with a hemocytometer, and resus-
bauer, M., et al. (1993). The CD40 ligand, gp39, is defective in acti-pended in fresh media for adoptive transfer.
vated T cells from patients with X-linked hyper-IgM syndrome. Cell
72, 291–300.
Adoptive Transfers Bachmann, M.F., Rohrer, U., Ku¨ndig, T.M., Bu¨rki, K., Hengartner,
Transfer recipients were sublethally irradiated (750 cGy) with X-rays H., and Zinkernagel, R.M. (1993). The influence of antigen organiza-
to eliminate endogenous lymphocytes and facilitate tracking of the tion on B cell responsiveness. Science 262, 1448–1451.
transferred B cells. Cells from B cell donors (4–12 3 106 splenocytes
Banchereau, F.B., Blanchard, D., Brie`re, F., Galizzi, J.P., van Kooten,containing 8–24 3 105 B cells) and T cell donors (3–7 3 105 CD41
C., Liu, Y.J., Rousset, F., and Saeland, S. (1994). The CD40 antigencells) were mixed on ice and injected via the lateral tail vein. Recipi-
and its ligand. Annu. Rev. Immunol. 12, 881–922.ent mice were sacrificed three or five days after transfer and spleen
Brunner, T., Mogil, R., LaFace, D., Yoo, N., Mahboubi, A., Echeverri,cell preparations were made by passing through a metal sieve. The
F., Martin, S., Force, W., Lynch, D., Ware, C., and Green, D. (1995)cells were counted by hemocytometer and suspended to appro-
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates acti-priate concentrations for flow cytometic analysis or spot ELISA
vation-induced apoptosis in T-cell hybridomas. Nature 373,(Rathmell and Goodnow, 1994) to determine the frequency of anti-
441–444.HEL IgMa secreting cells.
Choi, M.S.K. (1995). The role of bcl-xL in CD40-mediated rescue
from anti-m-induced apoptosis in WEHI-231 B lymphoma cells. Eur.Flow Cytometry
J. Immunol. 25, 1352–1357.Cells were analyzed with a Becton Dickinson FACScan (Mountain
Clark, E.A., and Ledbetter, J.A. (1994). How B and T cells talk toView, CA) as described (Rathmell et al., 1995). The following antigens
each other. Nature 367, 425–428.and antibodies were used: B220, RA3–6B2-fluorescein (FITC) or
phycoerythrin (PE; CALTAG); IgMa, RS3.1-FITC; Fas, Jo2-PE (Phar- Cohen, P.L., and Eisenberg, R.A. (1991). Lpr and gld: single gene
mingen, San Diego, CA); Ly5a, AS20-FITC; HEL, HyHEL9-TRIcolor models of systemic autoimmunity and lymphoproliferative disease.
(CALTAG custom conjugation); Thy1.2, Thy1.2-biotin (clone 5a-8, Annu. Rev. Immunol. 9, 243–269.
CALTAG); Syndecan, 281.2-biotin; and streptavidin-CyChrome
Cooke, M.P., Heath, A.W., Shokat, K.M., Zeng, Y., Finkelman, F.D.,
(Pharmingen). Absolute cell numbers for each experiment were de-
Linsley, P.S., Howard, M., and Goodnow, C.C. (1994). Immunoglobu-
termined by multiplying the frequency of B2201IgMa1 HEL-binding
lin signal transduction guides the specificity of B cell–T cell interac-
cells by the cell count as determined by hemocytometer.
tions and is blocked in tolerant self-reactive B cells. J. Exp. Med.
179, 425–438.
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